M. K. Al-banna, A. W. Kelman, and B. Whiting, Experimental design and efficient parameter estimation in population pharmacokinetics, Journal of Pharmacokinetics and Biopharmaceutics, vol.46, issue.4, pp.347-360, 1990.
DOI : 10.1007/BF01062273

A. C. Atkinson and A. N. Donev, Optimum Experimental Design, Oxford statistical science series, 1992.
DOI : 10.1007/978-3-642-04898-2_434

C. Bazzoli, S. Retout, and F. Mentré, Population design in nonlinear mixed effects multiple responses models: extension of PFIM and evaluation by simulation with NONMEM and MONOLIX, p.16, 2007.

S. L. Beal and L. B. Sheiner, NONMEM users guides, NONMEM, 1992.

V. V. Fedorov, Theory of optimal experiments, 1972.

V. V. Fedorov, R. C. Gagnon, and S. L. Leonov, Design of experiments with unknown parameters in variance, Applied Stochastic Models in Business and Industry, vol.84, issue.3, pp.207-218, 2002.
DOI : 10.1002/asmb.474

R. Gagnon and S. Leonov, OPTIMAL POPULATION DESIGNS FOR PK MODELS WITH SERIAL SAMPLING, Journal of Biopharmaceutical Statistics, vol.13, issue.1, pp.143-163, 2005.
DOI : 10.1002/0471725315

C. Godfrey, K. Sweeney, K. Miller, R. Hamilton, and J. Kremer, The population pharmacokinetics of long-term methotrexate in rheumatoid arthritis, British Journal of Clinical Pharmacology, vol.35, issue.4, pp.369-376, 1998.
DOI : 10.1046/j.1365-2125.1998.t01-1-00790.x

A. Hooker and P. Vicini, Simultaneous population optimal design for pharmacokineticpharmacodynamic experiments, pp.759-785, 2005.

E. N. Jonsson, J. R. Wade, and M. O. Karlsson, Comparison of some practical sampling strategies for population pharmacokinetic studies, Journal of Pharmacokinetics and Biopharmaceutics, vol.19, issue.2, pp.245-263, 1996.
DOI : 10.1007/BF02353491

A. Kavanaugh, E. W. St-clair, W. J. Mccune, T. Braakman, and P. Lipsky, Chimeric anti-tumor necrosis factor-alpha monoclonal antibody treatment of patients with rheumatoid arthritis receiving methotrexate therapy, The Journal of Rheumatology, vol.27, issue.4, pp.841-850, 2000.

E. Kuhn and M. Lavielle, Maximum likelihood estimation in nonlinear mixed effects models, Computational Statistics & Data Analysis, vol.49, issue.4, pp.1020-1038, 2005.
DOI : 10.1016/j.csda.2004.07.002

U. Klotz, A. Teml, and M. Schwab, Clinical Pharmacokinetics and Use??of??Infliximab, Clinical Pharmacokinetics, vol.20, issue.1, pp.46645-660, 2007.
DOI : 10.2165/00003088-200746080-00002

T. A. Louis, Finding the observed information matrix when using the EM algorithm, Journal of the Royal Statistical Society. Series B (Methodological), vol.44, issue.2, pp.226-233, 1982.

R. N. Maini, F. C. Breedveld, J. R. Kalden, J. S. Smolen, D. Davis et al., Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis, Arthritis and Rheumatism, issue.9, pp.411552-1563, 1998.

A. Mallet, A maximum likelihood estimation method for random coefficient regression models, Biometrika, vol.73, issue.3, pp.645-656, 1986.
DOI : 10.1093/biomet/73.3.645

F. Mentré, A. Mallet, and D. Baccar, Optimal design in random-effects regression models, Biometrika, vol.84, issue.2, pp.429-442, 1997.
DOI : 10.1093/biomet/84.2.429

G. C. Pillai, F. Mentré, and J. L. Steimer, Non-Linear Mixed Effects Modeling ??? From Methodology and Software Development to Driving Implementation in Drug Development Science, Journal of Pharmacokinetics and Pharmacodynamics, vol.72, issue.6, pp.161-183, 2005.
DOI : 10.1007/s10928-005-0062-y

J. C. Pinheiro and D. M. Bates, Approximations to the log-likelihood function in the nonlinear mixed-effects model, Journal of Computational and Graphical Statistics, vol.4, issue.1, pp.12-35, 1995.

S. Retout, E. Comets, A. Samson, and F. Mentré, Design in nonlinear mixed effects models: Optimization using the Fedorov???Wynn algorithm and power of the Wald test for binary covariates, Statistics in Medicine, vol.39, issue.28, pp.265162-5179, 2007.
DOI : 10.1002/sim.2910
URL : https://hal.archives-ouvertes.fr/hal-00263513

S. Retout, S. Duffull, and F. Mentré, Development and implementation of the population Fisher information matrix for the evaluation of population pharmacokinetic designs, Computer Methods and Programs in Biomedicine, vol.65, issue.2, pp.141-151, 2001.
DOI : 10.1016/S0169-2607(00)00117-6

S. Retout and F. Mentré, Further Developments of the Fisher Information Matrix in Nonlinear Mixed Effects Models with Evaluation in Population Pharmacokinetics, Journal of Biopharmaceutical Statistics, vol.13, issue.2, pp.209-227, 2003.
DOI : 10.1081/BIP-100101009

S. Retout and F. Mentré, Optimization of Individual and Population Designs Using Splus, Journal of Pharmacokinetics and Pharmacodynamics, vol.30, issue.6, pp.417-443, 2003.
DOI : 10.1023/B:JOPA.0000013000.59346.9a

S. Retout, F. Mentré, and R. Bruno, Fisher information matrix for non-linear mixed-effects models: evaluation and application for optimal design of enoxaparin population pharmacokinetics, Statistics in Medicine, vol.26, issue.6, pp.2623-2639, 2002.
DOI : 10.1002/sim.1041

A. Samson, M. Lavielle, and F. Mentré, Extension of the SAEM algorithm to left-censored data in nonlinear mixed-effects model: Application to HIV dynamics model, Computational Statistics & Data Analysis, vol.51, issue.3, pp.1562-1574, 2006.
DOI : 10.1016/j.csda.2006.05.007
URL : https://hal.archives-ouvertes.fr/inserm-00182360

L. B. Sheiner, B. Rosenberg, and K. L. Melmon, Modelling of individual pharmacokinetics for computer-aided drug dosage, Computers and Biomedical Research, vol.5, issue.5, pp.411-459, 1972.
DOI : 10.1016/0010-4809(72)90051-1

E. W. St-clair, C. L. Wagner, A. A. Fasanmade, B. Wang, T. Schaible et al., The relationship of serum infliximab concentrations to clinical improvement in rheumatoid arthritis: results from ATTRACT, a multicenter, randomized, double-blind, placebo-controlled trial, Arthritis and Rheumatism, issue.6, pp.461451-1459, 2002.

G. J. Van-breukelen, M. J. Candel, and M. P. Berger, Relative efficiency of unequal cluster sizes for variance component estimation in cluster randomized and multicentre trials, Statistical Methods in Medical Research, vol.18, issue.4, pp.439-458, 2008.
DOI : 10.1177/0962280206079018

E. Walter and L. Pronzato, Identification of parametric models from experimental data, 1997.

. Thoma, Communications and Control Engineering

H. P. Wynn, Results in the construction of D-optimum experimental designs, Journal of the Royal Statistical Society B, vol.34, pp.133-147, 1972.